Cristina S. M.
- Country
- Spain
- Department
- Oncology
Research Overview
- Safety, Tolerability, and Pharmacokinetics of Inavolisib Alone and in Combination with Endocrine and Targeted Therapies in Advanced Breast Cancer and Solid Tumors
- Evaluation of Tumor Infiltrating Lymphocytes in Advanced or Metastatic Triple-Negative Breast Cancer Patients
- A Phase 1, First-in-Human Study of MEN2312 as Monotherapy and in Combination Therapy in Participants with Advanced ER+/HER2- Breast Cancer
Data & Insights
Has run more than one trial at 163 of 381 partner sites.
Specializations
HER2-Related Breast Cancer Research
This investigator specializes in studying various manifestations of HER2-positive and HER2-low breast cancer, with particular attention to advanced and metastatic cases. Their research encompasses innovative therapeutic approaches including trastuzumab deruxtecan and novel combination treatments.
- Brain Metastases Management
- Advanced Breast Cancer Treatment
- Targeted Therapy Development
Hormone Receptor-Positive Cancer Studies
The investigator focuses on developing treatments for hormone receptor-positive breast cancer, particularly exploring combinations of endocrine therapy with targeted agents. Their work includes research on PIK3CA-mutated breast cancer and novel therapeutic approaches.
- Endocrine Therapy Resistance
- Metabolic Complications Management
- Combination Therapy Optimization
Advanced Solid Tumors Research
The investigator conducts research on advanced solid tumors with a focus on novel therapeutic agents and combination strategies. Their work includes studies of targeted molecular therapies and innovative treatment approaches for various cancer types.
- Novel Drug Development
- Molecular Targeting Strategies
- Treatment Resistance Mechanisms
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.